Smallwood R A, McIlveen B, Rosenoer V M, Sherlock S
Gut. 1971 Feb;12(2):139-44. doi: 10.1136/gut.12.2.139.
The plasma clearance and the liver uptake of intravenously administered (64)Cu were significantly impaired in four patients with Wilson's disease. These defects were unlikely to be simply expressions of the high liver copper concentration as the plasma clearance and hepatic uptake of (64)Cu were normal in four patients with primary biliary cirrhosis, in whom the liver copper concentration was raised to a degree comparable to that in Wilson's disease. The normal liver uptake and plasma clearance of (64)Cu in three patients with other forms of hepatocellular disease suggest that impaired liver cell function does not have a significant effect. The precise nature of the defect in copper transport in Wilson's disease remains to be elucidated; it is possible that delayed uptake of copper by the hepatic lysosomes may account for the toxic effects of the metal.
在4例威尔逊病患者中,静脉注射的(64)铜的血浆清除率和肝脏摄取明显受损。这些缺陷不太可能仅仅是肝脏铜浓度升高的表现,因为在4例原发性胆汁性肝硬化患者中,(64)铜的血浆清除率和肝脏摄取是正常的,而这些患者的肝脏铜浓度升高程度与威尔逊病患者相当。3例其他形式肝细胞疾病患者(64)铜的肝脏摄取和血浆清除正常,这表明肝细胞功能受损并没有显著影响。威尔逊病中铜转运缺陷的确切性质仍有待阐明;肝脏溶酶体对铜的摄取延迟可能是这种金属产生毒性作用的原因。